Abstracts

IL-6 hsCRP and the Development of Type 2 Diabetes Among HIV Positive Patients Taking ART

Background: Untreated HIV is associated with higher levels of inflammatory markers, and initiation of continuous antiretroviral therapy (ART) results in a decline, but does not normalize these markers. Inflammation is hypothesized to play a role in development of type 2 diabetes; however, clinical data addressing this issue among HIV positive patients have not been reported…

HbA1c Is a Poor Predictor of Fasting Glycemia in HIV-infected Men With Low CD4 Count High MCV and MCH

Background: Hemoglobin A1c (HbA1c) is the primary index of glycemic control in patients with diabetes and is also recommended for diagnosis. There is limited evidence that among HIV-infected patients, HbA1c values may not accurately reflect glycemia. Using data from the Multicenter AIDS cohort Study (MACS) we assessed HbA1C discordance (observed HbA1c – expected HbA1c) and…

Measuring Physical Activity and its Impact on Insulin Resistance in MACS Men

Background: Physical activity (PA) has many beneficial effects, including improved fitness, strength, quality of life, and decreased insulin resistance. Several small studies suggest that HIV-infected adults report inadequate PA. We examined the relationship between HIV status, PA and insulin resistance among men in the Multicenter AIDS Cohort Study (MACS). Methodology: The International Physical Activity Questionnaire…

Massive Expansion of HIV Infected Cells with Identical Proviruses in Patients on Suppressive ART

Background: Studies of HIV-1 population genetics during ART have shown the emergence of groups of identical sequences in plasma and PBMCs after long-term suppression. To investigate the mechanisms for the emergence of identical sequences on ART, we identified 14 patients with clonal HIV sequences during long-term therapy and determined their relationship to CD4+ T cell…

Transcripts Associated with the HIV Reservoir Correlate with the Pool Size of Long-lived CD4 T Cells

Background: Although active HIV-1 replication can be effectively suppressed by antiretroviral therapy (ART), the virus persists despite treatment and rapidly rebounds once treatment is discontinued. Prolonged ART initiated early after infection has been shown to reduce the size of the HIV-1 reservoir, however it does not eradicate the viral infection. This long-term viral persistence is…

Effects of CCR5-Δ32 Heterozygosity On HIV-1 Reservoir Size and Immune Activation

Background: The CCR5-Δ32 mutation in humans decreases cell surface expression of CCR5. To date, all three reported cases of HIV-1 eradication via bone marrow transplantation have been documented in CCR5-Δ32 heterozygotes. The contribution of CCR5-Δ32 heterozygosity to the observed eradication is as yet unknown. In this study, we examined the impact of CCR5-Δ32 heterozygosity on…

Seminal CMV Replication Immune Activation and Higher Proviral HIV DNA During Suppressive ART

Background: CMV replication is frequent in the genital tract of HIV infected men, and is associated with increased immune activation and HIV disease progression. We hypothesized that CMV-associated immune activation could influence the size of the HIV DNA reservoir during suppressive antiretroviral therapy (ART). Methodology: Paired blood and semen samples from 53 HIV infected men…

Persistent HIV in Plasma on during cART Can Lead to Rebound Viremia After Treatment Interruption

Background: Combination antiretroviral therapy (cART) suppresses but does not eradicate HIV infection. Analysis of HIV variants during cART has revealed populations of identical sequences, suggestive of clonally expanded populations, which have been found in plasma, in peripheral blood mononuclear cells (PBMC), as well as in anatomic compartments. HIV emerges rapidly after treatment interruption; rebound viremia…

Viral Dynamics of HIV-1 Rebound Viremia

Background: When combination antiretroviral therapy (cART) initiated in chronic HIV-1 infection is interrupted, virus quickly rebounds to near pretreatment levels. The functional latent reservoir is challenging to measure during suppressive cART; rebound HIV-1 virus populations arise directly from the functional latent reservoir, are the actual viruses that curative strategies need to interdict and may be…